325 Capital’s Biote Corp BTMD Stock Holding History

325 Capital’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.6M	Hold	4,548,127	–	–	2.05%	10
2026 Q1	$6.14M	Hold	4,548,127	–	–	2.24%	10
2025 Q4	$11.8M	Hold	4,548,127	–	–	4.14%	10
2025 Q3	$13.6M	Hold	4,548,127	–	–	4.15%	10
2025 Q2	$18.3M	Hold	4,548,127	–	–	7.22%	7
2025 Q1	$15.1M	Hold	4,548,127	–	–	6.27%	9
2024 Q4	$28.1M	Hold	4,548,127	–	–	10.87%	3
2024 Q3	$25.4M	Buy	4,548,127 +781,461	+21%	+$5.21M	10.75%	5
2024 Q2	$28.1M	Hold	3,766,666	–	–	11.82%	3
2024 Q1	$21.8M	Hold	3,766,666	–	–	10.09%	5
2023 Q4	$18.6M	Hold	3,766,666	–	–	9.22%	5
2023 Q3	$19.3M	Hold	3,766,666	–	–	15.91%	3
2023 Q2	$25.5M	Buy	3,766,666 +1,800,000	+92%	+$10.7M	16.78%	3
2023 Q1	$12.2M	Buy	+1,966,666	New	+$8.81M	10.64%	5

Other funds holding BTMD

Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

325 Capital's BTMD Position: Q2 2026 in Review

325 Capital held its Biote Corp (BTMD) position steady in Q2 2026 at 4,548,127 shares worth $8.6M. The position accounts for 2.05% of the portfolio, ranked #10.

325 Capital first reported a position in BTMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $28.1M in Q2 2024. 72 funds tracked by Wall St. Rank hold BTMD as of Q2 2026.

325 Capital held 4,548,127 shares of Biote Corp worth $8.6M as of Q2 2026.
325 Capital left its Biote Corp share count unchanged in Q2 2026.
Biote Corp made up 2.05% of 325 Capital's portfolio in Q2 2026, its #10 holding.
325 Capital first reported a position in Biote Corp in Q1 2023 and has held it in 14 quarters since.
325 Capital's Biote Corp position peaked at $28.1M in Q2 2024.
72 funds tracked by Wall St. Rank held Biote Corp as of Q2 2026.

Based on 325 Capital's 13F filing for Q2 2026, filed 14 Aug 2026.